Dr. Brian J. SnyderBrian J. Snyder, M.D. is a board certified neurosurgeon who specializes in the treatment of movement disorders such as Parkinson’s disease, tremor and dystonia, as well as seizure disorders and epilepsy. Dr. Snyder is an expert in deep brain stimulation (DBS) utilizing microelectrode recording, vagal nerve stimulation (VNS), and procedures for mapping, recording, and identifying seizure foci in the brain and the surgical resection of these foci.
Dr. Snyder received his undergraduate degree
in Biology from Dartmouth College in
Hanover, New Hampshire. He received his
medical degree from Temple University School
of Medicine where he was honored as AOA,
(Alpha Omega Alpha Honor Medical Society.)
At Mount Sinai School of Medicine he served as an intern in general surgery and advanced to a resident in neurological surgery and then chief resident in neurological surgery. Following this he pursued a fellowship in stereotactic and functional neurosurgery under Dr. Andres Lozano at the Toronto Western Hospital, University of Toronto. He has also obtained certiﬁcation in both Gamma Knife and ®Radiosurgery.
Dr. Snyder has published and presented extensively on ﬁelds in functional neurosurgery. His papers and presentations include works on surgery for primary dystonia,seizure outcomes associated with cavernous malformations, deep brain stimulation for depression and Parkinson’s disease as well as gamma knife treatment for tremor.
As a resident and fellow he was active in the American Association of Neurological Surgeons. He was elected to the Young Neurosurgeons Committee and subsequently was elected to serve as the liaison from the Young Neurosurgeons Committee to the executive committee of the American Society for Stereotactic and Functional Neurosurgery.
Lozano AM, Snyder BJ. Deep brain stimulation for parkinsonian gait disorders. J Neurol. 2008 Aug;255 Suppl 4:30-1. Review. PubMed PMID: 18821083.
Kong T, Choi JK, Park H, Choi BH, Snyder BJ, Bukhari S, Kim NK, Huang X, Park
SR, Park HC, Ha Y. Reduction in programmed cell death and improvement in
functional outcome of transient focal cerebral ischemia after administration of
granulocyte-macrophage colony-stimulating factor in rats. J Neurosurg. 2009 Apr
10. [Epub ahead of print] PubMed PMID: 19361262.
Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, Park H, Park HC, Park SR, Ha Y. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model. Eur J Neurosci. 2009 Mar;29(5):891-900. Epub 2009 Feb 24. PubMed PMID: 19245369.